31 SMART - VIRTUAL MEETING - Program November 13-15, 2020 - Eventi
←
→
Trascrizione del contenuto della pagina
Se il tuo browser non visualizza correttamente la pagina, ti preghiamo di leggere il contenuto della pagina quaggiù
SMART MEETING ANESTHESIA RESUSCITATION INTENSIVE CARE
31° SMART - VIRTUAL MEETING
November 13-15, 2020
Program
www.e-smart2020.org
Restiamo connessi!
ENDORSED BY
Sociètà di Anestesia e Rianimazione
Neonatale e Pediatrica Italiana
SMART MEETING ANESTHESIA RESUSCITATION INTENSIVE CARE
www.e-smart2020.org 31° SMART - VIRTUAL MEETING
www.smartonweb.org SMART - SCIENTIFIC BOARD
M. Antonelli, A. Braschi, G. Conti, L. Gattinoni,
A. Pesenti, M. Quintel, F. Raimondi, M. Senturk
SMART - SCIENTIFIC SECRETARIAT
G. Bellani, L. Brazzi, M. Girardis
SMART - SCIENTIFIC ADVISORY BOARD
H. Amirfarzan, M.M. Berger, L. Brochard, D. Brodie, P. Caironi,
M. Cecconi, G. Citerio, E. Cohen, D. De Luca, G. Grasselli,
P.M. Ingelmo, T. Langer, A. Lucchini, J.J. Marini, P.M. Mertes,
F. Mojoli, M. Panigada, D. Payen, P. Pelosi, F. Petrini, G. Ristagno,
S. Romagnoli, F. Sangalli, M. Singer, J.L. Vincent
SMART - ORGANIZING SECRETARIAT
Start Promotion Srl - Provider ECM 622
Via Mauro Macchi, 50 - 20124 Milano - Italy
Tel. +39 02 67071383 | Fax +39 02 67072294
Email: info@startpromotion.it | www.startpromotion.it
Faculty 6 Program 10 Non Accredited Sessions 23 Faculty - Non Accredited Sessions 25 Lunch Sessions 26 Meet the Expert Sessions 28 Simulation Sessions 30 Technical Forum 36 Abstracts 44 General Information 48
FA C U LT Y FA C U LT Y
Abrahão Hajjar L., São Paulo (BR) Cecconi M., Milano (I) Gallani M.C., Laval (CDN) Maggiore S.M., Chieti (I) Piccioni F., Milano (I) Spinelli E., Milano (I)
Agostini V., Genova (I) Chiumello D., Milano (I) Gattinoni L., Goettingen (D) Mancino A., Roma (I) Pickkers P., Nijmegen (NL) Stehle P., Bonn (D)
Albrecht E., Lausanne (CH) Citerio G., Monza (I) Girardis M., Modena (I) Marczin N., London (UK) Piquilloud L., Lausanne (CH) Szuldrzyński K., Krakow (PL)
Amirfarzan H., Boston (USA) Cohen E., New York (USA) Giussani C., Monza (I) Marini J.J., St. Paul (USA) Pittiruti M., Roma (I)
Antonelli M., Roma (I) Collino F., Milano (I) Gori A., Milano (I) Mascheroni D., Milano (I) Poulakou G., Athens (GR) Taccone F.S., Bruxelles (B)
Antonini V.M., Parma (I) Colombo D., Borgomanero (I) Grasselli G., Milano (I) Mattiussi E., Udine (I) Preiser J.C., Bruxelles (B) Talmor D., Boston (USA)
Artoni A., Milano (I) Coniglio C., Bologna (I) Grieco D.L., Roma (I) Mauri T., Milano (I) Procaccio F., Verona (I) Tavazzi G., Pavia (I)
Azoulay E., Paris (F) Constantin J.M., Paris (F) Grillo Padilha K., São Paulo (BR) McNicholas B., Galway (IRL) Protti A., Milano (I) Telias I., Toronto (CDN)
Conti G., Roma (I) Guarracino F., Pisa (I) Meissner K., Goettingen (D) Tesoro S., Perugia (I)
Badenes R., Valencia (E) Corradi F., Pisa (I) Guitton C., Le Mans (F) Merdji H., Strasbourg (F) Quintel M., Goettingen (D) Thille A.W., Poitiers (F)
Baillie K., Edinburgh (UK) Cortegiani A., Palermo (I) Mertes P.M., Strasbourg (F) Timsit J.F., Paris (F)
Bambi S., Firenze (I) Cremer O.L., Utrecht (NL) Hawchar F., Szeged (HU) Meyfroidt G., Leuven (B) Rachedi N., Roma (I) Tobin M., Chicago (USA)
Bandera A., Milano (I) Helbok R., Innsbruck (A) Mitzner S., Rostock (D) Ranieri V.M., Bologna (I) Tonetti T., Bologna (I)
Bassetti M., Genova (I) De Bus L., Ghent (B) Heunks L., Amsterdam (NL) Mojoli F., Pavia (I) Reintam Blaser A., Lucerne (CH) Torres A., Barcelona (E)
Behr A., Padova (I) De Ferrari G., Torino (I) Hörer T.M., Örebro (S) Molnar Z., Pécs (HU) Ristagno G., Milano (I) Tosi F., Roma (I)
Bellani G., Monza (I) De Luca D., Paris (F) Hutin A., Paris (F) Mongodi S., Pavia (I) Robba C., Genova (I)
Berger M., Durham (USA) De Pascale G., Roma (I) Montrucchio G., Torino (I) Rocco M., Roma (I) Vergano M., Torino (I)
Berger M.M., Lausanne (CH) De Waele J., Ghent (B) Ichai C., Nice (F) Mossetti V., Torino (I) Rocco P., Rio De Janeiro (BR) Viale P., Bologna (I)
Bignami E.G., Parma (I) Di Benedetto F., Modena Imazio M., Torino (I) Muiesan P., Birmingham (UK) Romagnoli S., Firenze (I) Vieillard-Baron A., Paris (F)
Blangetti I., Mondovì (I) Disma N., Genova (I) Ince C., Rotterdam (NL) Mussini C., Modena (I) Romano S.M., Firenze (I) Villa S., Monza (I)
Bonfanti P., Monza (I) Donadello K., Verona (I) Ingelmo P.M., Montreal (CDN) Myatra S.N., Mumbai (IND) Rossi S., Parma (I) Villar J., Las Palmas Gran Canaria (E)
Borrometi F., Napoli (I) Iozzo P., Palermo (I) Rossolini G., Firenze (I) Vincent J.L., Bruxelles (B)
Bouchez S., Ghent (B) Elli S., Monza (I) Negro A., Milano (I) Rubino A., Cambridge (UK) Volta C.A., Ferrara (I)
Bouhemad B., Dijon (F) Ercole A., Cambridge (UK) Johnston D., Belfast (UK) Nordberg P., Stockholm (S) Rubulotta F., London (UK)
Bouzat P., Grenoble (F) Juffermans N., Amsterdam (NL) Russo G., Lodi (I) Ware L.B., Nashville (USA)
Brazzi L., Torino (I) Fanelli A., Bologna (I) Ostermann M., London (UK) Russotto V., Monza (I) Wiegers E.J.A., Rotterdam (NL)
Brochard L., Toronto (CDN) Fassl J., Dresden (D) Kellum J., Pittsburgh (USA) Wiener-Kronish J., Boston (USA)
Brodie D., New York (USA) Ferguson N.D., Toronto (CDN) Kunst G., London (UK) Panigada M., Milano (I) Sacchi M., Milano (I) Wik L., Oslo (N)
Bruyneel A., La Louvière (B) Ferrando Ortolà C., Barcelona (E) Pasero D., Sassari (I) Sandroni C., Roma (I) Woolley T., Birmingham (UK)
Bugada D., Bergamo (I) Ferrer Roca R., Barcelona (E) Laffey J., Galway (IRL) Pasticci I., Milano (I) Sangalli F., Milano (I)
Busani S., Modena (I) Fontana C., Roma (I) Lamperti M., Abu Dhabi (UAE) Patroniti N., Genova (I) Scolletta S., Siena (I) Zanella A., Milano (I)
Forni L.G., Guildford (UK) Langer T., Milano (I) Payen D., Paris (F) Senturk M., Istanbul (TR) Zanierato M., Torino (I)
Caironi P., Torino (I) Foti G., Monza (I) Lascarrou J.B., Nantes (F) Pea F., Udine (I) Shankar-Hari M., London (UK) Zimmerman J., Houston (USA)
Camporota L., London (UK) Froulund Jensen J., Holbaek (DK) Lingsma H.F., Rotterdam (NL) Pellis T., Pordenone (I) Singer M., London (UK)
Cappelleri G., Bergamo (I) Fumagalli R., Milano (I) Locatelli C.A., Pavia (I) Pelosi P., Genova (I) Singh Y., Cambridge (UK)
Caricato A., Roma (I) Futier E., Clermont-Ferrand (F) Lönnqvist P.A., Stockholm (S) Pesenti A., Milano (I) Skrifvars M., Helsinki (F)
Cariou A., Paris (F) Lucchini A., Monza (I) Petrini F., Chieti-Pescara (I) Sorbello M., Catania (I)
Carron M., Padova (I) Galazzi A., Milano (I) Pham T., Paris (F) Spinella P.C., St. Louis (USA)
6 7
EDUCATIONAL ACCREDITATION OF THE
31° SMART - VIRTUAL MEETING
ECM accreditation
The 31° SMART - Virtual Meeting has been accredited by the Italian Ministry
of Health (27 ECM credits for year 2020). In the Italian system (ECM) the
meeting has been accredited as “FAD Sincrona - corsi in diretta su piattaforma
multimediale dedicata (aula virtuale, webinar)”. See page 52 for details.
EACCME® accreditation
The 31° SMART - Virtual Meeting has been accredited by the European
ALL TIMES STATED IN CET (Central European Time) Accreditation Council for Continuing Medical Education (EACCME®) with
18 European CME credits (ECMEC®s). In the European system (EACCME®/
UEMS) the meeting has been accredited as LEE (Live Educational Event).
See page 53 for details.
ACCREDITAMENTO FORMATIVO DEL
31° SMART - VIRTUAL MEETING
Accreditamento ECM
Il 31° SMART - Virtual Meeting è stato accreditato presso il Ministero della Salute
(27 crediti ECM per l’anno 2020). Nel sistema italiano (ECM), il meeting è stato
accreditato come “FAD Sincrona - corsi in diretta su piattaforma multimediale
dedicata (aula virtuale, webinar)”. Dettagli a pag. 52 .
Accreditamento EACCME®.
Il 31° SMART - Virtual Meeting è stato accreditato presso l’European Accreditation
Council for Continuing Medical Education (EACCME ®) con 18 Crediti CME
Europei (ECMEC®). Nel sistema europeo (EACCME®/UEMS), il meeting è stato
accreditato come LEE (Live Educational Event). Dettagli a pag. 53.
LANGUAGE: All the scientific sessions will be in English.
LINGUA: Tutte le sessioni scientifiche saranno in lingua inglese.
p r o g r a m f r i d ay n o v e m b e r 1 3 M O R NING | 9 .0 0 -1 2 .3 0 c e t
BROWN HALL 1 BROWN HALL 2 AMBER HALL 1 AMBER HALL 2 AMBER HALL 3 AMBER HALL 4
ECM - Modulo 1A ECM - Modulo 1B ECM - Modulo 1C ECM - Modulo 1D ECM - Modulo 1E ECM - Modulo 1F
HOT TOPICS IN CARDIAC TAILORING THERAPEUTIC STRATEGIES SEPSIS CODE HOT TOPICS IN PEDIATRIC ENERGY AND FEEDING SMART TUTORIALS 1
INTENSIVE CARE IN ACUTE BRAIN INJURY GUIDED BY... FROM ED TO THE ICU ANESTHESIA ROUTE Coordinator: TBD
Chairperson: F. Sangalli Chairperson: R. Helbok Chairperson: M. Girardis Chairperson: S. Tesoro Chairperson: M.M. Berger 9.00 Respiratory physiology:
the essential to manage
9.00 Pharmacological or mechanical 9.00 Pupillometry 9.00 Are clinical signs enough? 9.00 Reduction of risk in pediatric 9.00 Glutamine: a critical patient
circulatory support G. Citerio K. Donadello anesthesia: what should we why should we give it L. Heunks
in cardiogenic shock? know, what should we do P. Stehle
S. Bouchez 9.20 Brain ultrasound 9.20 Antibiotic strategy: N. Disma 9.30 Setting and monitoring
P. Bouzat always fast and furious? 9.20 Hypophosphatemia: mechanical ventilation
9.20 Organ dysfunction J. De Waele 9.20 Pediatric difficult airway a frequent in the restrictive patient
after LVAD implantation 9.40 ICP-derived parameters F. Tosi life-threatening issue G. Foti
N. Marczin G. Meyfroidt 9.40 Saline or balanced? C. Ichai
Albumin is better 9.40 Perioperative fluid management 10.00 Setting and monitoring
9.40 Hemodynamic and arterial 10.00 Brain tissue oxygenation P. Caironi in children: can we sum it all up 9.40 Glucose control: mechanical ventilation
elastance by pulse contour F.S. Taccone now? still actual? in the obstructive patient
in patients undergoing light 10.00 Vasopressors: T. Langer J.C. Preiser C.A. Volta
sedation for TAVI 10.20 qEEG myths and evidences
S.M. Romano A. Caricato M. Singer 10.00 Perioperative care in pediatric 10.00 Overfeeding: a killer 10.30 Cardiac output
anesthesia M.M. Berger measurement techniques
10.00 The importance of cardiovascular 10.40 Discussion 10.20 Source control: A. Mancino S. Scolletta
coupling in the daily management an essential but overlooked 10.20 Intermittent enteral
of critically ill patients 11.00 Break and Exhibition Visit treatment 10.20 Close-to-the-nerve vs. feeding the first week? 11.00 Break and Exhibition Visit
F. Guarracino R. Ferrer Roca interfascial plane blocks: J.C. Preiser
sniper rifle vs shotgun
10.20 Arterial stiffness: assessment 10.40 Discussion P.A. Lönnqvist 10.40 Discussion
and clinical implications
S. Scolletta 11.00 Break and Exhibition Visit 10.40 Discussion 11.00 Break and Exhibition Visit
10.40 Discussion 11.00 Break and Exhibition Visit
11.00 Break and Exhibition Visit
ECM - Modulo 2A ECM - Modulo 2B ECM - Modulo 2C ECM - Modulo 2D ECM - Modulo 2E ECM - Modulo 2F
HOT TOPICS IN TRAUMATIC BRAIN INJURY 2020: INNOVATION IN THORACIC ESP N IC En d o rs e me n t METABOLIC SUPPORT: SMART TUTORIALS 2
CARDIOTHORACIC ANESTHESIA CENTER-TBI ANESTHESIA POINT-OF-CARE ULTRASOUND WHAT AND HOW MUCH Coordinator: TBD
Chairperson: N. Marczin Chairperson: C. Robba Chairperson: E.G. Bignami IN PICU AND NICU Chairperson: C. Ichai 11.30 High flow nasal cannula:
Chairperson: G. Conti indications and technique
11.30 Tubeless thoracic surgery: 11.30 Center-TBI: 11.30 Protective ventilation 11.30 Optimal feeding route A. Cortegiani
myth or reality? what is changing in TBI in thoracic surgery 11.30 ESPNIC guidelines for in sepsis
E. Cohen epidemiology and early M. Senturk point-of-care ultrasound A. Reintam Blaser 12.00 Understanding a gas analysis:
treatment? in PICU and NICU from numbers to the respiratory
11.45 When is 3D echo H.F. Lingsma 11.45 Should we follow the Y. Singh 11.45 How to use indirect and cardiocirculatory status
essential, when useful, driving pressure for calorimetry L. Camporota
when it’s a waste of time? 11.45 ICU patients: optimal management 11.45 How to optimize the use of M.M. Berger
J. Fassl data from Center-TBI of OLV? ultrasound for vascular accesses 12.30 Lunch Break
E.J.A. Wiegers F. Piccioni M. Pittiruti 12.00 Individualized feeding
12.00 Neuromonitoring C. Ichai
and neurocognitive 12.00 Extracranial complications: 12.00 Bioengineered lung: 12.00 Lung ultrasound in pediatric
outcomes in cardiac impact on outcome is that the future? critical care: where are we? 12.15 Discussion
surgery G. Citerio E. Cohen D. De Luca
G. Kunst 12.30 Lunch Break
12.15 Discussion 12.15 Discussion 12.15 Discussion
12.15 Discussion
12.30 Lunch Break 12.30 Lunch Break 12.30 Lunch Break
12.30 Lunch Break
10 11
p r o g r a m f r i d ay n o v e m b e r 1 3 A F TE R NO O N | 1 4 .3 0 -1 8 .0 0 ce t
BROWN HALL 1 BROWN HALL 2 AMBER HALL 1 AMBER HALL 2 AMBER HALL 3 AMBER HALL 4
ECM - Modulo 3A ECM - Modulo 3B ECM - Modulo 3C ECM - Modulo 3D ECM - Modulo 3E ECM - Modulo 3F
VENOARTERIAL ISCHEMIC ARTERIAL PRESSURE MONITORING: EXTRACORPOREAL THERAPIES ULTRASOUND IS MY BEDSIDE SMART TUTORIALS 3
ECMO STROKE WHERE AND HOW? IN SEPSIS TOOL FOR… PART 1 Coordinator: TBD
Chairperson: D. Brodie Chairperson: G. Citerio Chairperson: D. Payen Chairperson: A. Pesenti Chairperson: F. Rubulotta 14.30 The mechanical power
as a target for VILI
14.30 E-CPR: 14.30 Anesthesia and intensive care 14.30 MAP-targeted fluid resuscitation 14.30 Cytokine removal 14.30 Neuromonitoring prevention
where are we going? for acute ischemic stroke should be abandoned! C. Ince C. Robba F. Collino
A. Hutin P. Bouzat Z. Molnar
14.50 Endotoxin removal 14.50 Pain management 15.00 Cardiocirculatory
14.50 Monitoring during 14.50 Ischemic stroke 2020: more and 14.50 The clinical interest of arterial M. Antonelli G. Russo physiology: the essential
VA-ECMO more aggressive with treatments elastance for the clinician to manage a critical
F. Sangalli R. Helbok D. Payen 15.10 An international registry on the 15.10 Lung monitoring patient
use of extracorporeal absorption S. Mongodi D. Payen
15.10 Extracorporeal organ support 15.10 Mechanical ventilation in stroke 15.10 Arterial pressure and cardiac F. Hawchar
for DCD: perspective and limits patients: is there a consensus? output, just a matter 15.30 Hemodynamic 15.30 101 Brain monitoring
M. Sacchi C. Robba of resistance? 15.30 A bioreactor for immune management for anesthesiologists
M. Singer support G. Tavazzi and intensivists
15.30 DCD heart retrieval 15.30 Decompressive craniectomy S. Mitzner H. Amirfarzan
and transplantation for ischemic stroke: 15.30 Discussion 15.50 Discussion
A. Rubino is it worth doing? 15.50 Discussion 16.00 Break and Exhibition Visit
C. Giussani 16.00 Break and Exhibition Visit 16.00 Break and Exhiition Visit
15.50 Discussion 16.00 Break and Exhibition Visit
15.50 Discussion
16.00 Break and Exhibition Visit
16.00 Break and Exhibition Visit
ECM - Modulo 4A ECM - Modulo 4B ECM - Modulo 4C ECM - Modulo 4D ECM - Modulo 4E ECM - Modulo 4F
IMPROVING ORGAN AVAILABILITY NOVEL ASPECTS OF WHAT’S NEW IN ACUTE RENAL ULTRASOUND IS MY BEDSIDE SMART TUTORIALS 4
FOR TRANSPLANT ANALGOSEDATION IN THE ICU PAIN THERAPY FAILURE TOOL FOR… PART 2 Coordinator: TBD
Chairperson: F. Procaccio Chairperson: D. Pasero Chairperson: F. Borrometi Chairperson: J. Zimmerman Chairperson: F. Rubulotta 16.30 Correct use of cardiovascular
drugs in the critical patient
16.30 What can we do? 16.30 Dexmedetomidine for sedation 16.30 Opioid effect and side 16.30 AKI biomarkers 16.30 Setting the ventilator F. Guarracino
R. Badenes in the ICU effect variability B. McNicholas F. Mojoli
G. Conti K. Meissner 17.00 Echocardiography in the
16.50 What we actually do 16.50 Acute kidney injury 16.50 Renal function management of septic shock
M. Zanierato 16.50 Volatile anesthetics 16.50 Opiod-sparing anesthetic and ventilator settings assessment G. Tavazzi
G. Foti strategies A. Vieillard-Baron F. Corradi
17.10 Optimizing the lung E. Albrecht 17.30 Basic echocardiographic
A. Zanella 17.10 Epidural analgesia in the ICU 17.10 PRO-CON DEBATE 17.10 An integrated approach evaluation of the cardiac
J.M. Constantin 17.10 Can we prevent chronic Furosemide: to the surgical patient function
17.30 Optimizing the liver postsurgical pain with when and how? B. Bouhemad F. Corradi
P. Muiesan 17.30 Discussion regional anesthesia? Pro: J. Kellum
V. Mossetti Con: D. Payen 17.30 Monitoring of weaning
17.50 Discussion from mechanical
17.30 How are you going to 17.50 Discussion ventilation
treat persistent chronic S. Mongodi
postsurgical pain?
P.M. Ingelmo 17.50 Discussion
17.50 Discussion
12 13
program SATURDAY november 14 M O R NING | 9 .0 0 -1 2 .3 0 c e t
BROWN HALL 1 BROWN HALL 2 AMBER HALL 1 AMBER HALL 2 AMBER HALL 3 AMBER HALL 4
ECM - Modulo 5A ECM - Modulo 5B ECM - Modulo 5C ECM - Modulo 5D ECM - Modulo 5E ECM - Modulo 5F
ADJUNCTIVE THERAPIES IN ARTIFICIAL INTELLIGENCE DIFFICULT INFECTIONS ELECTROLYTES IN THE ICU: COVID-19 BEYOND SMART TUTORIALS 5
COVID-19 CRITICALLY ILL PATIENTS AND BIG DATA IN DIFFICULT PATIENTS ANYTHING NEW? RESPIRATORY FAILURE Coordinator: TBD
Chairperson: G. Poulakou Chairperson: E.G. Bignami Chairperson: A. Bandera Chairperson: L.G. Forni Chairperson: L. Brazzi 9.00 Nutritional strategy
in the critically ill
9.00 Steroids? Yes, of course 9.00 Technology for managing 9.00 Co-infection in influenza 9.20 Low sodium concentration 9.00 Secondary infections: M.M. Berger
K. Baillie the complexity J.F. Timsit in the critically ill: virus or treatments ?
A. Ercole when to worry? G. Grasselli 9.30 Sedation in the ICU
9.20 Heparin: time and dose 9.20 How to improve antibiotic L. Gattinoni J.M. Constantin
M. Panigada 9.20 Artificial intelligence: effectiveness in the ICU: 9.20 Neurological complications
the way to go for Intensive TDM approach 9.40 Electrolytes in the urine: H. Merdji 10.00 Basic interpretation
9.40 The double edged sword Care Medicine F. Pea how to use them? of acid base balance
of cytokine blockade M. Cecconi P. Caironi 9.40 The role of renal failure T. Langer
therapies 9.40 Infections in ECMO patients and its management
S. Busani 9.40 PRO-CON DEBATE G. Grasselli 10.00 Electrolytes and acid-base M. Ostermann 10.30 Fluid management
Is research from Big Data equilibrium: where is the M. Cecconi
10.00 Antibiotic therapy reliable? 10.00 Oncology and hematology linkage? 10.00 Post-COVID Syndrome:
G. Montrucchio Pro: E.G. Bignami patients T. Langer the need for a multidisciplinary 11.00 Break and Exhibition Visit
Not sure: O.L. Cremer P. Pickkers approach
10.20 Discussion Con: M. Girardis 10.20 Hyperchloremic acidosis: P. Bonfanti
10.20 Fungal recommendations. a new way to control it
11.00 Break and Exhibition Visit 10.30 Discussion What if patient is critically ill? A. Zanella 10.20 Discussion
M. Bassetti
11.00 Break and Exhibition Visit 10.40 Discussion 11.00 Break and Exhibition Visit
10.40 Discussion
11.00 Break and Exhibition Visit
11.00 Break and Exhibition Visit
ECM - Modulo 6A ECM - Modulo 6B ECM - Modulo 6C ECM - Modulo 6D ECM - Modulo 6F
HOT TOPICS IN THE ICU ABDOMINAL ISSUES MECHANICAL VENTILATION NASAL HIGH FLOW OXYGEN IN THE SMART TUTORIALS 6
Chairperson: S. Rossi IN THE ICU PATIENT AND VILI CLINICAL ARENA: PATIENT CASES Coordinator: TBD
Chairperson: A. Reintam Blaser Chairperson: N. Juffermans AND NEW INDICATIONS 11.30 It’s up to you: new bedside
11.30 Conservative oxygen therapy Chairperson: T. Mauri signals to set the ventilator
during MV in the ICU 11.45 Abdominal infections as 11.30 Impact of PEEP on RV function D. Colombo
M. Girardis a sepsis source: diagnosis A. Vieillard-Baron 11.30 Clinical and physiological
and management effects of NHF in 12.00 Fluid management
11.45 Immune checkpoint inhibitors F. Di Benedetto 11.45 Mechanical power, VILI and tracheotomized patients in hemorrhagic shock
in sepsis: where are we? mortality: what are the links? S.M. Maggiore T. Woolley
M. Shankar-Hari 12.00 Microbiota in the ICU: T. Tonetti
not only a gut problem 11.45 NHF in patients with 12.30 Lunch Break
12.00 New therapy‑related A. Gori 12.00 Intraoperative mechanical postoperative respiratory failure
life‑threatening toxicity ventilation A.W. Thille
in patients with malignancies. 12.15 Discussion C. Ferrando Ortolà
What the intensivist should know 12.00 Combination of NHF and
E. Azoulay 12.30 Lunch Break 12.15 Discussion extracorporeal CO2 removal
in patients with acute asthma
12.15 Discussion 12.30 Lunch Break G. Grasselli
12.30 Lunch Break 12.15 Discussion
12.30 Lunch Break
14 15
program SATURDAY november 14 A F TE R NO O N | 1 4 .3 0 -1 8 .0 0 ce t
BROWN HALL 1 BROWN HALL 2 AMBER HALL 1 AMBER HALL 2 AMBER HALL 3 AMBER HALL 4
ECM - Modulo 7A ECM - Modulo 7B ECM - Modulo 7C ECM - Modulo 7D ECM - Modulo 7E ECM - Modulo 7F
ESOPHAGEAL PRESSURE INTERACTIVE SESSION HYPOTHERMIA VS. NORMOTHERMIA NEW STRATEGIES FOR EXTRACORPOREAL LIFE SMART TUTORIALS 7
AND PEEP TITRATION CHALLENGING SCENARIOS AFTER CARDIAC ARREST: WHAT IS THE DIFFICULT BUGS SUPPORT: NEW EVIDENCES - PART 1 Coordinator: TBD
Chairperson: P. Rocco TARGET IN TTM? NEW & OLD EVIDENCES Chairperson: M. Bassetti Chairperson: N. Patroniti
Chairperson: S. Romagnoli 14.30 Perioperative optimization
Chairperson: C. Sandroni S. Romagnoli
14.30 Determinants of 14.30 Necrotising fasciitis 14.30 New strategies in identification 14.30 ECCO2R for COPD. Time for
esophageal-pleural pressure beyond first hours 14.30 PRO therapeutic hypothermia and treatment of invasive fungal a new star: the ORION study 15.00 Optimal use of antibiotics
relationship in normal man G. De Pascale, A. Bandera (33°C): the evidence from the infections V.M. Ranieri in the ICU
I. Pasticci FINNRESUSCI and TTH48 J. De Waele J.F. Timsit
15.00 How to treat severe CAP M. Skrifvars 14.50 Lung recruitability in
14.50 The neglected variable in A. Cortegiani, J. De Waele 14.50 Stratification of patients at risk ECMO-treated ARDS patients 15.30 Diagnosis of cerebral or cardiac
mechanical ventilation: lung 14.50 CONTRA therapeutic hypothermia for carbapenem resistant L. Camporota death for organ donation
volumes and transpulmonary in favor of normothermia (36°C): infections
15.30 Patients with cardiac M. Zanierato
pressures the evidence from the TTM P. Viale 15.10 Sedation and early mobilization
dysfunction and sepsis
L. Gattinoni T. Pellis in ECMO
S. Romagnoli, F. Guarracino 16.00 Break and Exhiition Visit
15.10 Targeted temperature management
15.10 Empiric therapy for D. Brodie
15.10 Is esophageal pressure reflective 16.00 Break and Exhibition visit for cardiac arrest with the superbugs
of pleural pressure? nonshockable rhythm: the new M. Bassetti 15.30 The future of ECMO trials
D. Chiumello evidence from the HYPERION trial N.D. Ferguson
A. Cariou 15.30 How to dose new antibiotics
15.30 Esophageal pressure to guide F. Pea 15.50 Discussion
PEEP titration: does it make 15.30 Early intra-arrest cooling: does it
sense? works? The evidence from the 15.50 Discussion 16.00 Break and Exhiition Visit
M. Quintel PRINCESS trial
P. Nordberg 16.00 Break and Exhiition Visit
15.50 Discussion
15.50 Discussion
16.00 Break and Exhibition Visit
16.00 Break and Exhiition Visit
ECM - Modulo 8A ECM - Modulo 8B ECM - Modulo 8C ECM - Modulo 8D ECM - Modulo 8E ECM - Modulo 8F
SEPSIS SCIENCE: AIRWAY MANAGEMENT IN IMPROVING CARDIOPULMONARY UNSOLVED QUESTIONS EXTRACORPOREAL LIFE PRO-CON DEBATE
PEARLS AND PITFALLS CRITICALLY ILL PATIENTS RESUSCITATION IN TRAUMA SUPPORT: NEW EVIDENCES - PART 2 THE BEST RESPIRATORY TREATMENT
Chairperson: L. Abrahão Hajjar Chairperson: S.N. Myatra Chairperson: G. Ristagno Chairperson: C. Fontana Chairperson: V.M. Antonini FOR COVID-19 PNEUMONIA
Chairperson: L.B. Ware
16.30 The 12 elements that can 16.30 Intubation-related morbidity 16.30 What is quality of CPR? Much 16.30 Golden hour in trauma: 16.30 ECMO: is it over?
improve outcome in sepsis and mortality - the Intube more than chest compression is it still enough? D. Talmor 16.30 COVID-19 is a typical ARDS
J.L. Vincent study results depth, fraction, and rate N. Rachedi J. Laffey
V. Russotto L. Wik 16.50 PRO-CON DEBATE
16.50 Sepsis phenotypes: a step 16.50 Resuscitation and hemostasis: ECMO improves oxygenation 16.50 COVID-19 is an atypical ARDS
forward to personalized 16.50 Role of videolaryngoscopes 16.50 What is the best ventilation overload vs under-resuscitation. Pro: A. Pesenti
strategy during CPR? L. Gattinoni
treatments in the ICU Could whole blood be the Con: M. Quintel
D. Payen J.B. Lascarrou G. Ristagno solution? 17.10 Approach early intubation
P.C. Spinella 17.10 Discussion with trepidation
17.10 Resuscitative endovascular
17.10 Has Sepsis-3 changed my 17.10 Does high-flow nasal cannula M. Tobin
balloon occlusion of the aorta
approach to septic patient? reduce intubation problems? 17.10 Hemorragic shock:
for refractory cardiac arrest
M. Shankar-Hari C. Guitton to tube or not to tube? 17.30 Late intubation is a disaster
C. Coniglio
T. Woolley J.J. Marini
17.30 Sepsis and fake news: putting 17.30 Human factors in airway 17.30 Extracorporeal cardiopulmonary
data in perspective management resuscitation in refractory 17.30 Pre-hospital use of REBOA 17.50 Discussion
M. Singer M. Sorbello cardiac arrest: to whom and when in uncontrollable bleedings
M. Skrifvars T.M. Hörer
17.50 Discussion 17.50 Discussion
17.50 Neurophysiology and neuroimaging 17.50 Discussion
to predict poor neurological
outcome after cardiac arrest
C. Sandroni
18.10 Discussion
16 17
program SUNDAY november 15 M O R NING | 9 .0 0 -1 2 .3 0 c e t
BROWN HALL 1 BROWN HALL 2 AMBER HALL 1 AMBER HALL 2 AMBER HALL 3 AMBER HALL 4
ECM - Modulo 9A ECM - Modulo 9B ECM - Modulo 9C ECM - Modulo 9D ECM - Modulo 9E ECM - Modulo 9F
UPDATE ON MDR/XDR SMART NURSING SEPSIS BEYOND REGIONAL ANESTHESIA IN PERIOPERATIVE MANAGEMENT SMART TUTORIALS 9
MICROORGANISMS: INFECTION CONTROL IN THE ICU THE FIRST HOUR THE DAILY CLINICAL PRACTICE OF VENTILATION Coordinator: TBD
PREVENTION, FAST MICROBIOLOGY DURING COVID-19 PANDEMIC Chairperson: K. Donadello Chairperson: A. Behr Chairperson: N. Juffermans 9.00 Perioperative
AND MANAGEMENT Chairperson: E. Mattiussi thromboprophylaxis
Chairperson: G. De Pascale 9.20 Is it time for small volume 9.00 Chest wall plane blocks and 9.00 PRO-CON DEBATE M. Panigada
9.00 The burden of ICU and low pressure approach? cancer breast surgery: evidence Is low tidal volume ventilation
9.00 Reducing the risk: successful environmental contamination M. Singer and outcomes protective in anesthesia? 9.30 Arterial pressure control during
strategies in infection control V. Russotto D. Johnston Pro: J. Laffey general anesthesia to prevent
C. Mussini 9.40 When I need more: rationale Con: D. Mascheroni postoperative organ damage
9.20 The dark side of mobile calling for adjunctive therapies 9.20 Abdominal wall blocks: should E. Futier
9.20 Fast and syndromic approach in the ICU P. Pickkers we give up the epidural? 9.40 The issue of perioperative
to microorganisms A. Galazzi D. Bugada hyperoxia 10.00 Anesthesia for interventional
G. Rossolini 10.00 Blood purification: C. Ferrando Ortolà cardiac procedures
9.40 Vascular access devices evidences and hopes 9.40 Enhanced recovery strategies F. Guarracino
9.40 How to identify patient at risk in COVID-19 patients S. Romagnoli for total knee replacement 10.00 Noninvasive oxygenation support
P. Viale S. Elli G. Cappelleri in perioperative medicine 10.30 Anaphylaxis in anesthesia
10.20 The long-term effects of sepsis J.M. Constantin P.M. Mertes
10.00 New mechanisms of resistance 10.00 The “chlorhexidine ICU affair”: M. Shankar-Hari 10.00 New blocks for thoracic
and novel antibiotics what’s new, what’s old surgery: a new tool? 10.20 The role of blood transfusion 11.00 Break and Exhibition Visit
J.F. Timsit S. Bambi 10.40 Discussion M. Senturk in perioperative respiratory
failure
10.20 De-escalation: when and how 10.20 Medical masks and respirators 11.00 Break and Exhibition Visit 10.20 Regional anesthesia for N. Juffermans
L. De Bus for the protection from outpatients: to do or not to do?
SARS-CoV-2 A. Fanelli 10.40 Discussion
10.40 Discussion P. Iozzo
10.40 Discussion 11.00 Break and Exhibition Visit
11.00 Break and Exhibition Visit 10.40 Discussion
11.00 Break and Exhibition Visit
11.00 Break and Exhibition Visit
ECM - Modulo 10A ECM - Modulo 10B ECM - Modulo 10C ECM - Modulo 10D ECM - Modulo 10E ECM - Modulo 10F
ACUTE RESPIRATORY SMART NURSING LOOKING OUTSIDE THE USUAL BOX: FASCIA PLANE BLOCKS: NONINVASIVE VENTILATION SMART TUTORIALS 10
DISTRESS SYNDROME HUMANIZING THE INTENSIVE NON ISCHEMIC CAUSES OF FACT OR FICTION? Chairperson: M. Rocco Coordinator: TBD
OR SIMPLY ARF? CARE UNIT CARDIOGENIC SHOCK Chairperson: D. Johnston 11.30 Strategy for the
Chairperson: L.B. Ware Chairperson: R. Fumagalli Chairperson: I. Blangetti 11.30 Noninvasive ventilation versus difficult-to-intubate patient
11.30 The cornerstone of fascia oxygen therapy in patients with M. Sorbello
11.30 Lessons from the 11.30 How to implement a nurse 11.30 Stress cardiomyopathies plane blocks acute respiratory failure
LUNG SAFE study led follow-up program G. Tavazzi A. Behr D.L. Grieco 12.00 Managing postoperative pain
A. Pesenti J. Froulund Jensen D. Bugada
11.45 Arrhythmogenic 11.45 Fact 11.45 How to maximize the chances
11.45 Protective ventilation in 11.45 ICU diary: an Italian experience cardiomyopathies D. Johnston of NIV success? 12.30 Lunch Break
non-ARDS patients: S. Villa G. De Ferrari G. Foti
different rules? 12.00 Fiction
P. Pelosi 12.00 Introducing the video call during 12.00 Fulminant myocarditis A. Fanelli 12.00 The use of noninvasive
COVID-19 pandemic M. Imazio ventilation to facilitate
12.00 The Radiographic Assessment A. Negro 12.15 Discussion weaning and early extubation
of Lung Edema (RALE) score, 12.15 Discussion A.W. Thille
a new tool for quantifying 12.15 Discussion 12.30 Lunch Break
pulmonary edema on the 12.30 Lunch Break 12.15 Discussion
chest radiograph 12.30 Lunch Break
L.B. Ware 12.30 Lunch Break
12.15 Discussion
12.30 Lunch Break
18 19program SUNDAY november 15 A F TE R NO O N | 1 4 .3 0 -1 8 .0 0 ce t
BROWN HALL 1 BROWN HALL 2 AMBER HALL 1 AMBER HALL 2 AMBER HALL 3 AMBER HALL 4
ECM - Modulo 11A ECM - Modulo 11B ECM - Modulo11C ECM - Modulo 11D ECM - Modulo 11E ECM - Modulo 11F
ACID BASE/ELECTROLYTES SMART NURSING ARDS ANESTHESIA AND COGNITION WEANING FROM MECHANICHAL SMART TUTORIALS 11
Chairperson: M. Ostermann NURSING WORKLOAD IN THE ICU Chairperson: M. Quintel Chairperson: J. Wiener-Kronish VENTILATION: NEW ISSUES Coordinator: TBD
Chairperson: M.C. Gallani AND NEW SOLUTIONS? - PART 1 14.30 Cardiocirculatory evaluation
14.30 Yes, again Stewart. 14.30 Dexamethasone in ARDS: 14.30 Anesthesiologist’s guide Chairperson: I. Telias and management of the
But, do you remember it? 14.30 The evaluation of nursing a successful story to monitor the brain non-cardiac surgical patient
J. Kellum workload in an Italian J. Villar H. Amirfarzan 14.30 Where are we at with weaning? R. Fumagalli
ECMO Center A snapshot from the WEAN
14.50 Boston rules: what’s really A. Lucchini 14.50 Steroids in ARDS: 14.50 Perioperative neurocognitive SAFE study 15.00 Management of oliguria:
behind these numbers? a skeptical approach disorders and Alzheimer’s T. Pham a pragmatic approach
T. Langer 14.50 Multicenter study results of NAS G. Grasselli disease J. Kellum
and Nurse Sensitive Outcomes M. Berger 14.50 Is P0.1 clinically useful
15.10 Diagnosis and management in 2017 15.10 Steroids in pneumonia in difficult weaning? 15.30 Challenges in pre-hospital
of hypernatremia in the ICU K. Grillo Padilha A. Torres 15.10 Intraoperative EEG monitoring L. Brochard trauma management
C. Ichai and depth of sedation C. Fontana
15.10 Pilot experiences with NAS 15.30 Steroids and Vitamin C H. Amirfarzan 15.10 Sedation-rehabilitation:
15.30 Potassium everywhere: in the CHU de Québec in ALI/ARDS: a word of wisdom a complex intervention 16.00 Break and Exhibition Visit
intravenous fluids in renal failure and IUCPQ J.J. Marini 15.30 Best practices for postoperative in the ICU
P. Caironi M.C. Gallani brain health and outcomes J.M. Constantin
15.50 Discussion in older adults
15.50 Discussion 15.30 Prospective study in M. Berger 15.30 Role of patient-ventilator
15 hospitals in Belgium 16.00 Break and Exhibition Visit dyssynchrony
16.00 Break and Exhibition Visit A. Bruyneel 15.50 Discussion F. Mojoli
15.50 Discussion 16.00 Break and Exhibition Visit 15.50 Discussion
16.00 Break and Exhibition Visit 16.00 Break and Exhibition Visit
ECM - Modulo 12A ECM - Modulo 12B ECM - Modulo 12C ECM - Modulo 12D ECM - Modulo 12E ECM - Modulo 12F
COAGULOPATHY IN GOING ABOVE THERAPY IN RECRUITING THE LUNG CONTROVERSIES IN WEANING FROM MECHANICHAL SMART TUTORIALS 12
THE CRITICALLY ILL THE ICU Chairperson: P. Rocco GENERAL ANESTHESIA VENTILATION: NEW ISSUES Coordinator: TBD
Chairperson: V. Agostini Chairperson: M. Vergano Chairperson: F. Petrini AND NEW SOLUTIONS? - PART 2 16.30 How to improve
16.30 Lung recruitment. Chairperson: E. Spinelli patient-ventilator synchrony
16.30 Sepsis and coagulation, 16.30 Communication in the ICU If, when, how 16.30 Quality and safety in the L. Piquilloud
anything new? L.B. Ware N.D. Ferguson operating room 16.30 The role of pendelluft in
K. Szuldrzyński P.M. Mertes weaning: any clinical relevance? 17.00 Recreational drugs:
16.50 Rounds at the bedside: 16.50 Recruitment in ARDS: G. Bellani how do they affect anesthesia
16.50 Severe thrombophilia we could do better how to measure? 16.50 Is deep neuromuscular C.A. Locatelli
in intensive care J.L. Vincent L. Brochard block a standard of care? 16.50 Does mode of method matter?
A. Artoni M. Carron J.J. Marini 17.30 Procedural sedation
17.10 Families and patients will never 17.10 Recruiting maneuvers during M. Lamperti
17.10 Antithrombin during ECMO: walk alone: tracheotomy in anesthesia: the good, the bad, 17.10 Insights from i.v. morphine 17.10 Discussion
rationale and current practice critically ill patients the ugly! and hydromorphone
A. Protti P. Pelosi P. Pelosi pharmacokinetics
J. Wiener-Kronish
17.30 Is there a place for antithrombin 17.30 Discussion 17.30 Discussion
during ECMO? 17.30 Discussion
M. Panigada
17.50 Discussion
20 21ALL TIMES STATED IN CET (Central European Time) NON ACCREDITED SESSIONS
Lunch Sessions, Meet the Expert Sessions, Simulation Sessions and Technical
Forums are NOT subjected to ECM/EACCME® accreditation.
No ECM and no ECMEC® credits can be claimed for attending these sessions.
SESSIONI NON ACCREDITATE
Lunch Session, Meet the Expert, Simulation Session e Technical Forum NON
rientrano nel percorso di accreditamento ECM/EACCME ® e pertanto non danno
diritto ad alcun credito formativo italiano (ECM) né europeo (ECMEC ®).
LANGUAGE: English or Italian, no simultaneous translation.
LINGUA: Inglese o Italiano, senza traduzione simultanea.FA C U LT Y - N O N A C C R E D I T E D S E S S I O N S
Abrahão Hajjar L., São Paulo (BR) Foti G., Monza (I) Paternoster G., Potenza (I)
Arisi E., Pavia (I) Fumagalli R., Milano (I) Pea F., Udine (I)
Pesenti A., Milano (I)
Bellani G., Monza (I) Gattinoni L., Goettingen (D) Pittiruti M., Roma (I)
Berlot G., Trieste (I) Girardis M., Modena (I) Pugin J., Genève (CH)
Bernardi M., Bologna (I) Grasso S., Bari (I) Pulvirenti S., Novara (I)
Bouhemad B., Dijon (F) Grieco D.L., Roma
Brazzi L., Torino (I) Guarracino F., Pisa (I) Quintel M., Goettingen (D)
Caironi P., Torino (I) Herpain A., Bruxelles (B) Rauseo M., Foggia (I)
Camporota L., London (UK) Resta M., S. Donato Milanese (I)
Carron M., Padova (I) Lucchini A., Monza (I) Rezoagli E., Monza (I)
Cecchetti C., Roma (I) Romito F., Matera (I)
Chiumello D., Milano (I) Maggiorini M., Lucerne (CH) Ronco C., Vicenza (I)
Cortese G., Torino (I) Messina A., Milano (I)
Cosentini R., Bergamo (I) Mojoli F., Pavia (I) Sard P., Milano (I)
Cotoia A., Foggia (I) Montenegro R., Roma (I) Shankar-Hari M., London (UK)
Monti G., Milano (I)
Dalfino L., Bari (I) Montrucchio G., Torino (I) Valenza F., Milano (I)
Donati A., Ancona (I) Mussa B., Torino (I) Viale P., Bologna (I)
Vincent J.L., Bruxelles (B)
Elisei D., Macerata (I) Nierhaus A., Hamburg (D) Vismara S., Monza (I)
Nocci M., Siena (I)
Ferrer Roca R., Barcelona (E) Zanierato M., Torino (I)
24 25L U N C H S E S S I O N S | 12.45-14. 15 ce t L U N C H S E S S I O N S | 1 2 .4 5 -1 4 .1 5 ce t
Access to Lunch Sessions is possible from the Sponsor’s virtual booth and/or from the Lobby. Access to Lunch Sessions is possible from the Sponsor’s virtual booth and/or from the Lobby.
L’ accesso alle Lunch Session è possibile dallo stand virtuale dell’Azienda Sponsor e/o dalla Lobby. L’ accesso alle Lunch Session è possibile dallo stand virtuale dell’Azienda Sponsor e/o dalla Lobby.
FRIDAY NOVEMBER 13 FRIDAY NOVEMBER 13 SATURDAY NOVEMBER 14 SUNDAY NOVEMBER 15
BROWN HALL 1 AMBER HALL 1 BROWN HALL 1 BROWN HALL 1
12.45 - 14.15 12.45 - 14.15 12.45 - 14.15 12.45 - 14.15
LUNCH SESSION LUNCH SESSION LUNCH SESSION LUNCH SESSION
ENDOTOXIC SHOCK: USE, ABUSE AND MISUSE OF TACKLING SEPSIS-INDUCED ALBUMIN IN 2020 AND BEYOND…
POLYMYXIN B HEMOPERFUSION NONINVASIVE VENTILATORY IMMUNOSUPPRESSION
Supported by CSL BEHRING,
AS COMPLEMENTARY THERAPY SUPPORT IN THE COVID-19 ERA Supported by BIOTEST GRIFOLS, KEDRION BIOPHARMA
Supported by ESTOR Supported by INTERSURGICAL Chairpersons: L. Brazzi, M. Girardis Chairpersons: L. Gattinoni, M. Quintel
Chairpersons: R. Ferrer Roca, A. Pesenti Chairperson: L. Brazzi
12.45 Best practice for the use of 12.45 Albumin oxidation:
12.45 Endotoxic shock: the trigger, 12.45 Which lung characteristics IgM-enriched IgG in patients physiological meaning
the host and role of targeted are we facing? with sepsis L. Gattinoni
blood purification L. Gattinoni A. Nierhaus
M. Girardis 13.05 Cirrhosis, the non-oncotic
13.05 When and how should 13.05 Immunodysfunction properties of albumin matter
13.05 Early neutralization of endotoxin we approach noninvasive in patients with sepsis M. Bernardi
in the intraoperative setting ventilation? M. Shankar-Hari
J. Pugin G. Foti 13.25 Iso- vs. hyper-oncotic
13.25 Potential role of immunoglobulins albumin-containing solutions
13.25 Polymyxin B hemoperfusion in 13.25 CPAP in emergency in COVID-19 patients P. Caironi
the general ICU: when and why R. Cosentini L. Abrahão Hajjar
F. Romito 13.45 Hypo-albuminemia as harmful
13.45 What clinical results have 13.45 Effects of the timing of factor: cause or effect?
13.45 Precision therapy and sequential we achieved? administration of IgM- and J.L. Vincent
therapies: advanced strategies in L. Camporota IgA-enriched intravenous polyclonal
sepsis-induced AKI immunoglobulins on the outcome 14.05 Discussion
C. Ronco 14.05 Discussion of septic shock patients
G. Berlot
14.05 Discussion
14.05 Discussion
26 27MEET THE EXPERT SESSIONS MEET THE EXPERT SESSIONS
Meet the Expert Sessions offer the opportunity of an informal and direct interaction between SMART participants
and recognized Experts in selected topics. They will take place in the Meet the Expert Corner, a dedicated
space accessible from both the Lobby and the Sponsor’s virtual booth. Admission is free but limited to max 80
participants, on a first-come first-served basis.
Le Meet the Expert Session offrono la possibilità di un’interazione veloce e diretta con Esperti riconosciuti su alcuni temi di interesse.
Si svolgono in uno spazio dedicato, il Meet the Expert Corner, accessibile dalla Lobby e dallo stand virtuale dell’Azienda Sponsor.
Partecipazione a numero chiuso, max 80 partecipanti. Accesso libero fino ad esaurimento posti.
MEET THE EXPERT CORNER FRIDAY NOVEMBER 13 | 11.00 - 12.00 CET MEET THE EXPERT CORNER SATURDAY NOVEMBER 14 | 11.30 - 12.30 CET
EMPRESSIoNi: from theory to clinical practice How to manage vHAP and VAP
EMPRESSIoNi: dalla teoria alla pratica clinica Come gestire la vHAP e la VAP
EXPERT: M. Resta Supported by MODERATOR: P. Viale | EXPERTS: L. Dalfino, F. Pea Supported by
MEET THE EXPERT CORNER FRIDAY NOVEMBER 13 | 14.30 - 15.30 CET MEET THE EXPERT CORNER SATURDAY NOVEMBER 14 | 13.00 - 14.00 CET
Hemodynamics at the bedside with the Pulse Contour Cardiac Output (PiCCO) BLOC LANDIO: ß1-selectivity in the clinical practice
Emodinamica al posto letto con il Pulse Contour Cardiac Output (PiCCO) BLOC LANDIO: la ß1-selettività nella pratica clinica
MODERATOR: S. Grasso | EXPERTS: C. Cecchetti, R. Fumagalli Supported by EXPERT: G. Paternoster Supported by
MEET THE EXPERT CORNER FRIDAY NOVEMBER 13 | 16.00 - 17.00 CET
Different hemodynamic effects of inotropes and their clinical consequences
Differenti effetti emodinamici degli inotropi e loro implicazioni cliniche
MODERATOR: F. Guarracino | EXPERT: A. Herpain Supported by
28 29SIMULATION SESSIONS SIMULATION SESSIONS
Simulation Sessions will take place in the Simulation Center, a dedicated space accessible from both the Lobby SIMULATION CENTER FRIDAY NOVEMBER 13 | 14.30 - 15.30 CET
and the Sponsor’s virtual booth. Admission is limited to max 80 participants with mandatory pre-registration. See
page 51 for details.
Le Simulation Session si svolgono all’interno del Simulation Center accessibile dalla Lobby e dallo stand virtuale dell’Azienda Sponsor.
La partecipazione è a numero chiuso, max 80 partecipanti, con pre-iscrizione obbligatoria. Dettagli a pagina 51. 3 Supported by &
Simulation Session 3 SPEAKERS: M. Carron, G. Cortese
SIMULATION CENTER FRIDAY NOVEMBER 13 | 11.30 - 12.30 CET
AN ES T H ES I A PERIOPERATIVE MANAGEMENT OF OBESE PATIENTS
1
The purpose of this scenario is to discuss the main problems of the perioperative
Supported by & management of obese patients. The topics of positioning on the operating table and airway
management will be addressed with particular attention to different technologies ensuring
a safe transition from spontaneous breathing to anesthesia (traditional laryngoscopy,
fibrobrocoscopy, videolaryngoscopy). The topic of intraoperative management will
Simulation Session 1 SPEAKERS: F. Mojoli, E. Arisi then be addressed, focusing on monitoring techniques and healthcare targets useful to
guarantee an opioid-sparing anesthesia management in line with the latest international
recommendations. Finally, the methods of optimizing awakening from anesthesia and safe
M ECHANIC AL OPTIMIZATION OF PATIENT-VENTILATOR SYNCHRONY DURING
discharge from the operating block will be discussed, aiming at an early mobilization and
ASSISTED VENTILATION
VENTILATIO N The purpose of this simulation scenario is to train attendees on how to optimize patient-
adequate monitoring of the spontaneous respiratory function.
ventilator synchrony during assisted ventilation. Different scenarios of patient-ventilator
interaction will be simulated and their clinical implications will be discussed. GESTIONE PERIOPERATORIA DEL PAZIENTE OBESO
Scopo di questo scenario è offrire ai partecipanti l’opportunità di confrontarsi con le principali
problematiche della gestione perioperatoria del paziente obeso. Saranno illustrati il posizionamento
OTTIMIZZAZIONE DELLA SINCRONIZZAZIONE PAZIENTE-VENTILATORE
sul tavolo operatorio e la gestione delle vie aeree, con particolare attenzione alle tecnologie che
IN VENTILAZIONE ASSISTITA
garantiscono un passaggio sicuro dal respiro spontaneo all’anestesia (laringoscopia tradizionale,
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training su come sia possibile fibrobrocoscopia, videolaringoscopia). Si affronterà poi la gestione intraoperatoria, con particolare
ottimizzare la sincronizzazione paziente-ventilatore in ventilazione assistita. Saranno simulati attenzione alle tecniche di monitoraggio ed ai target assistenziali utili a garantire una gestione
diversi scenari di interazione paziente-ventilatore e ne saranno discusse le implicazioni cliniche. anestesiologica il più possibile opioid-sparing, in linea con le più recenti raccomandazioni
internazionali. Verranno infine discusse le modalità di ottimizzazione del risveglio dall’anestesia
e della dimissione sicura dal blocco operatorio, con l’obiettivo di garantire una mobilizzazione
precoce ed un monitoraggio adeguato della funzione respiratoria spontanea.
SIMULATION CENTER FRIDAY NOVEMBER 13 | 13.00 - 14.00 CET
SIMULATION CENTER FRIDAY NOVEMBER 13 | 15.45 - 16.45 CET
2 Supported by
4 Supported by
Simulation Session 2 SPEAKERS: G. Monti, M. Nocci
Simulation Session 4 SPEAKERS: G. Bellani, E. Rezoagli
CLINICA L EARLY WARNING SCORE PROTOCOLS TO EFFICIENTLY IDENTIFY
M O NITO RING
PATIENTS AT RISK MEC H AN I C AL ADVANCED TOOLS TO ASSESS RESPIRATORY MECHANICS
The purpose of this simulation scenario is to offer an overview of the potential benefits AND PATIENT-VENTILATOR INTERACTION
that the introduction of Early Warning Score protocols can bring in term of clinical patient
VEN T I LAT I ON The purpose of this simulation scenario is to train attendees in the main parameters
outcomes and improved staff workflow. Rapid identification of patient deterioration can be (numeric or derived from waveform observation), which allow monitoring of various
difficult by monitoring single parameters because clinical staff is alerted only after important aspects of a patient’s ventilator interaction at the bedside, in different modes of assisted
physiological changes. The Early Warning Score enables the healthcare professionals to ventilation. Patients-ventilator synchrony and estimation of patient’s effort will be explored
quickly identify patients at risk and reduce adverse events in general ward. and the most frequent abnormal findings will be simulated and their clinical implications will
be discussed.
PROTOCOLLI EARLY WARNING SCORE PER UNA EFFICIENTE IDENTIFICAZIONE
DEI PAZIENTI A RISCHIO STRUMENTI AVANZATI PER LA VALUTAZIONE DELLA MECCANICA RESPIRATORIA E DELLA
Lo scopo di questo scenario di simulazione è fornire una visione generale dei potenziali vantaggi INTERAZIONE PAZIENTE-VENTILATORE
legati all’introduzione dei protocolli Early Warning Score in termini di miglioramento degli outcome Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training sui principali
clinici e del flusso di lavoro del personale sanitario. La rapida identificazione del deterioramento parametri (numerici o derivati dall’osservazionen delle forme d’onda), che permettono il
delle condizioni del paziente può essere difficile se basata sul monitoraggio di singoli parametri, monitoraggio dei vari aspetti dell’interazione paziente-ventilatore al posto letto, in diverse
perché lo staff clinico viene allertato solo dopo variazioni fisiologiche importanti. L’Early Warning modalità di ventilazione assistita. Saranno analizzate la sincronizzazione paziente-ventilatore e
Score permette ai clinici di identificare rapidamente i pazienti a rischio e di ridurre gli eventi avversi la stima dello sforzo respiratorio del paziente, saranno simulate le anomalie più frequentemente
nei reparti di degenza ordinaria. riscontrate nella pratica clinica e ne saranno discusse le implicazioni cliniche.
30 31SIMULATION SESSIONS SIMULATION SESSIONS
SIMULATION CENTER SATURDAY NOVEMBER 14 | 10.00 - 11.00 CET SIMULATION CENTER SATURDAY NOVEMBER 14 | 15.30 - 16.30 CET
5 Supported by 8 Supported by
Simulation Session 5 SPEAKERS: G. Foti, E. Rezoagli Simulation Session 8 SPEAKERS: G. Foti, E. Rezoagli
SETTING THE VENTILATOR DURING ASSISTED VENTILATION
M ECHANIC AL ALVEOLAR RECRUITMENT AND PEEP SETTING BASED ON RESPIRATORY MEC H AN I C AL The purpose of this simulation scenario is to train attendees on how to face the main
MECHANICS
VENTILATIO N The purpose of this simulation scenario is to train attendees in the possible approaches to
VEN T I LAT I ON challenges encountered when ventilating a patient with increased airway resistance,
obstructive or restrictive disease, such COPD, ARDS or lung fibrosis. These will include
perform alveolar recruitment maneuvers and to titrate PEEP while taking into account the detection and measurement of increased airway resistance and reduced compliance.
data derived from respiratory mechanics. The most relevant pathologic alterations of these
parameters will be simulated and their clinical implications will be discussed.
IMPOSTAZIONE DEL VENTILATORE IN VENTILAZIONE ASSISTITA
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training su come affrontare
RECLUTAMENTO ALVEOLARE E IMPOSTAZIONE DELLA PEEP
le principali problematiche che si manifestano durante la ventilazione di un paziente con una
IN BASE ALLA MECCANICA RESPIRATORIA
aumentata resistenza delle vie aeree, una patologia ostruttiva o restrittiva, per esempio BPCO o
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training sui possibili approcci ARDS o fibrosi polmonare. Tra le problematiche verranno considerate la rilevazione e la misura di
utilizzabili per realizzare manovre di reclutamento alveolare e per dosare la PEEP in base ai dati una aumentata resistenza delle vie aeree e di una ridotta compliance.
derivati dalle misure di meccanica respiratoria. Saranno simulate le alterazioni patologiche più
rilevanti di questi parametri e ne saranno discusse le implicazioni cliniche
SIMULATION CENTER SATURDAY NOVEMBER 14 | 12.45 - 13.45 CET SIMULATION CENTER SUNDAY NOVEMBER 15 | 10.00 - 11.00 CET
7 Supported by 9 Supported by &
Simulation Session 7 SPEAKERS: B. Bouhemad, D. Chiumello Simulation Session 9 SPEAKERS: M. Carron, G. Cortese
M ECHANIC A L IMPROVING ARDS MANAGEMENT BASED ON RESPIRATORY MECHANICS AN ES T H ES I A PERIOPERATIVE MANAGEMENT OF OBESE PATIENTS
AND ULTRASOUND ASSESSMENT The purpose of this scenario is to discuss the main problems of the perioperative
VENTILATIO N The purpose of this simulation scenario is to discuss and train attendees on how the management of obese patients. The topics of positioning on the operating table and airway
assessment of respiratory mechanics, mechanical power and lung-muscle ultrasound could management will be addressed with particular attention to different technologies ensuring
optimize the management of ARDS patients. Different scenarios will be considered and a safe transition from spontaneous breathing to anesthesia (traditional laryngoscopy,
their clinical implications discussed. fibrobrocoscopy, videolaryngoscopy). The topic of intraoperative management will
then be addressed, focusing on monitoring techniques and healthcare targets useful to
guarantee an opioid-sparing anesthesia management in line with the latest international
MIGLIORARE LA GESTIONE DELL’ ARDS SULLA BASE DELLA MECCANICA RESPIRATORIA
recommendations. Finally, the methods of optimizing awakening from anesthesia and safe
E DELLA VALUTAZIONE ECOGRAFICA
discharge from the operating block will be discussed, aiming at an early mobilization and
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un’occasione di confronto e adequate monitoring of the spontaneous respiratory function.
di training su come sia possibile ottimizzare la gestione dei pazienti con ARDS attraverso la
valutazione della meccanica respiratoria, del mechanical power e dell’ecografia del polmone e
del muscoli respiratori. Saranno presi in considerazione diversi scenari e ne saranno discusse le GESTIONE PERIOPERATORIA DEL PAZIENTE OBESO
implicazioni cliniche. Scopo di questo scenario è offrire ai partecipanti l’opportunità di confrontarsi con le principali
problematiche della gestione perioperatoria del paziente obeso. Saranno illustrati il posizionamento
sul tavolo operatorio e la gestione delle vie aeree, con particolare attenzione alle tecnologie che
garantiscono un passaggio sicuro dal respiro spontaneo all’anestesia (laringoscopia tradizionale,
fibrobrocoscopia, videolaringoscopia). Si affronterà poi la gestione intraoperatoria, con particolare
attenzione alle tecniche di monitoraggio ed ai target assistenziali utili a garantire una gestione
anestesiologica il più possibile opioid-sparing, in linea con le più recenti raccomandazioni
internazionali. Verranno infine discusse le modalità di ottimizzazione del risveglio dall’anestesia
e della dimissione sicura dal blocco operatorio, con l’obiettivo di garantire una mobilizzazione
precoce ed un monitoraggio adeguato della funzione respiratoria spontanea.
32 33SIMULATION SESSIONS
SIMULATION CENTER SUNDAY NOVEMBER 15 | 11.30 - 12.30 CET
10 Supported by
Simulation Session 10 SPEAKER: M. Pittiruti
ULTRASOUND ULTRASONOGRAPHIC VASCULAR ACCESS
The purpose of this simulation scenario is to train attendees on how to choose the best
vascular access device, how to check the pertinent vascular anatomy of the patient, and
how to place a vascular device by ultrasound guide, with particular emphasis on peripherally
inserted central venous catheters (PICCs). Through a structured ad rational approach,
participants will learn how to identify abnormal states and acquire the essential skills for an
effective insertion of last-generation vascular access devices.
ACCESSO VASCOLARE CON TECNICA ECOGRAFICA
Lo scopo di questo scenario di simulazione è offrire ai partecipanti un training su come scegliere
il miglior dispositivo di accesso vascolare, come controllare l’anatomia vascolare pertinente
nei pazienti, e come posizionare un dispositivo di accesso vascolare sotto guida ecografica, in
particolare i cateteri venosi centrali ad inserzione periferica (PICC). Attraverso un approccio
strutturato e razionale, i partecipanti impareranno come identificare anomalie anatomiche ed
acquisiranno le competenze fondamentali per un efficace posizionamento dei dispositivi di accesso
vascolare di ultima generazione.
34 35TECHNICAL FORUM TECHNICAL FORUM
Technical Forums will take place in the Technical Forum Corner, a dedicated space accessible from both the Lobby
and the Sponsor’s virtual booth. Admission is free but limited to max 80 participants, on a first-come first-served TECHNICAL FORUM CORNER FRIDAY NOVEMBER 13 | 14.30 - 15.30 CET
basis.
I Technical Forum si svolgeranno in uno spazio dedicato, il Technical Forum Corner, accessibile dalla Lobby e dallo stand virtuale
dell’Azienda Sponsor. Partecipazione a numero chiuso, max 80 partecipanti. Accesso libero fino ad esaurimento posti. SPEAKERS: R. Montenegro, P. Sard, S. Vismara
PrisMax: WHAT IF CRRT TRAINING WAS EASIER AND MORE ACCESSIBLE?
Intensive care nurses face the need to cope with very sophisticated devices which
TECHNICAL FORUM CORNER FRIDAY NOVEMBER 13 | 11.00 - 12.00 CET sometimes they don’t use in their daily practice, as well as to manage clinical
emergencies requiring the use of equipment they have never operated before, and
Supported by this must be implemented as fast as possible. The purpose of this Technical Forum is
SPEAKERS: L. Brazzi, M. Zanierato to introduce the PrisMax Educational Portal, an innovative portal designed to provide
healthcare professionals with an easy and effective training on the complex system of
extracorporeal therapies.
TELECONSULTATION IN CRITICAL CARE: SCIENCE, NOT SCIENCE FICTION
In many clinical settings an immediate expert consultation is essential to identify the
PrisMax: E SE IL TRAINING SULLA CRRT FOSSE PIÙ SEMPLICE E PIÙ ACCESSIBILE?
most appropriate diagnostic strategy or approach. Remote presence solutions enable
clinicians to activate a real-time teleconsultation, with simultaneous patient assessment Gli infermieri di terapia intensiva si trovano a far fronte alla gestione di apparecchiature
Supported by and diagnostic imaging. In the context of a particularly complex procedure such as molto complesse e talvolta non utilizzate quotidianamente, così come a gestire emergenze che
donation after circulatory death with the use of extracorporeal circulatory support implicano l’utilizzo di macchinari mai utilizzati, da implementare nel minor tempo possibile. Lo
to preserve organs for transplantation, we will see how this opportunity is not only scopo di questo Technical Forum è di presentare il Portale Educazionale PrisMax, un portale
strategic but almost essential. innovativo per la formazione semplice ed efficace degli operatori sanitari sul complesso sistema
delle terapie extracorporee.
TELECONSULTO IN AREA CRITICA: SCIENZA, NON FANTASCIENZA
Molti sono gli ambiti in cui un consulto immediato con un esperto è indispensabile per
identificare la strategia o l’approccio diagnostico più corretto. Le soluzioni di presenza remota
consentono di eseguire una televisita, in tempo reale, con la contemporanea valutazione
paziente e diagnostica per immagini. Nell’ambito di una procedura di particolare complessità
come la donazione a cuore fermo con impiego del supporto circolatorio extracorporeo per la
preservazione degli organi a scopo di trapianto, vedremo come tale opportunità sia non solo
strategica ma quasi irrinunciabile.
TECHNICAL FORUM CORNER FRIDAY NOVEMBER 13 | 16.00 - 17.00 CET
SPEAKERS: A. Donati, M. Girardis, G. Montrucchio
PROGNOSIS AND THERAPY OPTIMIZATION IN THE CRITICALLY ILL PATIENT
IN THE COVID-19 ERA: ARE WE CLOSE TO A BREAKTHROUGH ?
Adrenomedullin (ADM) is a peptide whose levels have been found high in several
TECHNICAL FORUM CORNER FRIDAY NOVEMBER 13 | 13.00 - 14.00 CET pathological conditions. A laboratory method is now available, enabling the measurement
of one of its fragments (proADM) whose levels seem to be associated with prognosis in
the critically ill, so that it is supposed to have a role as an early marker in septic shock
SPEAKERS: G. Bellani, D.L. Grieco Supported by and potentially also in the COVID-19 patient. What clinical role could be played by this
biomarker and what answers can it provide? What role for a combined use of proADM
and other biomarkers? This will be discussed with experts of the topics who have tested
CUSTOMIZATION OF RESPIRATORY SUPPORT IN ARDS its applicability in the clinical practice.
Supported by
Bedside measurement of lung volumes can be a useful tool to optimize parameters of
mechanical ventilation in the critically ill patient. The purpose of this Technical Forum is
PROGNOSI E OTTIMIZZAZIONE DELLA TERAPIA NEL PAZIENTE CRITICO
to present the rationale and discuss clinical applications of this technique.
IN EPOCA COVID-19: SIAMO VICINI AD UNA SVOLTA?
L’adrenomedullina (ADM) è un peptide i cui livelli sono elevati in diversi quadri patologici. È
INDIVIDUALIZZAZIONE DEL SUPPORTO RESPIRATORIO NELL’ARDS oggi disponibile la misura di un suo frammento (proADM) i cui livelli appaiono correlati con la
prognosi del paziente critico tanto da farne ipotizzare un ruolo come marcatore precoce nello
La misura dei volumi polmonari, realizzata al posto letto, è uno strumento utile per ottimizzare i shock settico, e potenzialmente anche nel paziente COVID-19. Quale potrà essere il ruolo
parametri della ventilazione meccanica nel paziente critico. Lo scopo di questo Technical Forum clinico per questo biomarker e quali risposte potrà fornire? Quale ruolo per un uso combinato
è illustrare il razionale ed esaminare le diverse applicazioni cliniche di questa tecnica. con altri biomarcatori? Se ne parla con esperti del settore che ne hanno provato l’applicabilità
nella pratica clinica.
36 37Puoi anche leggere
